This work analyzed the in-vivo pharmacokinetic profile of SMB extract, evaluated its effects on CF and MC apoptosis in HF rats, and explored its relationship with the regulation of the PI3K/Akt/mTOR SPW, thus yielding a basis for clinical application of SMB extract in HF treatment. Here, AKT1 is linked to cystic fibrosis.